Deborah Jean Anderson PhD

Professor, Infectious Diseases

Professor, Other OB/GYN

670 Albany St | (617) 414-8482
dande@bu.edu
deborah.anderson@bmc.org

Sections

Infectious Diseases

Biography

I have expertise in mucosal immunology, and secondarily in virology. I am interested in immune defense of the genital tract against sexually-transmitted pathogens. We are currently working with epithelial cell lines and HIV-1 infection models.

Other Positions

Websites

Education

Immunology, PhD, University of Texas at Austin

Immunology, MS, University of Texas at Austin

Biology, BA, Rice University

Publications

Published on 3/6/2024

Nador E, Xia C, Santangelo PJ, Whaley KJ, Costello CE, Anderson DJ. Platform-Specific Fc N-Glycan Profiles of an Antisperm Antibody. Antibodies (Basel). 2024 Mar 06; 13(1). PMID: 38534207.

PubMed

Published on 2/13/2024

Johnson JA, Li JF, Politch JA, Lipscomb JT, Santos Tino A, DeFelice J, Gelman M, Anderson DJ, Mayer KH. HIV Immunocapture Reveals Particles Expressed in Semen under INSTI-based Therapy are Largely Myeloid Cell-Derived and Disparate from Circulating Provirus. J Infect Dis. 2024 Feb 13. PMID: 38356153.

PubMed

Published on 1/9/2024

Dohadwala S, Geib MT, Politch JA, Anderson DJ. Innovations in monoclonal antibody-based multipurpose prevention technology (MPT) for the prevention of sexually transmitted infections and unintended pregnancy. Front Reprod Health. 2023; 5:1337479. PMID: 38264184.

PubMed

Published on 6/13/2023

Dohadwala S, Politch JA, Barmine JH, Anderson DJ. A Brief History and Advancement of Contraceptive Multipurpose Prevention Technology (cMPT) Products. Open Access J Contracept. 2023; 14:83-94. PMID: 37332341.

PubMed

Published on 4/13/2023

Anderson DJ, Johnston DS. A brief history and future prospects of contraception. Science. 2023 Apr 14; 380(6641):154-158. PMID: 37053322.

PubMed

Published on 3/30/2023

Mausser E, Nador E, Politch JA, Pauly MR, Marathe JG, Moench TR, Zeitlin L, Whaley KJ, Anderson DJ. LALAPG variant of the Human Contraception Antibody (HCA) reduces Fc-mediated effector functions while maintaining sperm agglutination activity. PLoS One. 2023; 18(3):e0282147. PMID: 36996137.

PubMed

Published on 3/2/2023

Thurman AR, Moench TR, Hoke M, Politch JA, Cabral H, Mausser E, Nador E, Morton J, Hamorsky K, Swope K, Bratcher B, Anderson DJ, Whaley KJ. ZB-06, a vaginal film containing an engineered human contraceptive antibody (HC4-N), demonstrates safety and efficacy in a phase 1 postcoital test and safety study. Am J Obstet Gynecol. 2023 Jun; 228(6):716.e1-716.e12. PMID: 36870409.

PubMed

Published on 10/31/2022

Lee SG, Kiattiburut W, Khongkha T, Schinkel SCB, Lunn Y, Decker AP, Mohammadi A, Vera-Cruz A, Misra A, Angel JB, Anderson DJ, Baker M, Kaul R, Wang G, Tanphaichitr N. 17BIPHE2, an engineered cathelicidin antimicrobial peptide with low susceptibility to proteases, is an effective spermicide and microbicide against Neisseria gonorrhoeae. Hum Reprod. 2022 Oct 31; 37(11):2503-2517. PMID: 36053257.

PubMed

Published on 8/13/2022

Patten JJ, Keiser PT, Morselli-Gysi D, Menichetti G, Mori H, Donahue CJ, Gan X, Valle ID, Geoghegan-Barek K, Anantpadma M, Boytz R, Berrigan JL, Stubbs SH, Ayazika T, O'Leary C, Jalloh S, Wagner F, Ayehunie S, Elledge SJ, Anderson D, Loscalzo J, Zitnik M, Gummuluru S, Namchuk MN, Barabási AL, Davey RA. Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization. iScience. 2022 Sep 16; 25(9):104925. PMID: 35992305.

PubMed

Published on 9/2/2021

Anderson DJ. Passive immunization of the human vagina. Hum Vaccin Immunother. 2022 Apr 29; 18(2):1965423. PMID: 34473605.

PubMed

View full list of 303 publications.